Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117422) titled 'Venetoclax-Decitabine in Untreated Elderly/Unfit AML' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The Second Hospital of Hebei Medical University
Condition:
AML, Adult
Intervention:
Drug: VEN + DEC
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 17, 2025
Target Sample Size: 39
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117422
Disclaimer: Curated by HT Syndication....